Clinical and genetic characteristics of type I sialidosis patients in mainland China

Ann Clin Transl Neurol. 2020 Jun;7(6):911-923. doi: 10.1002/acn3.51058. Epub 2020 May 29.

Abstract

Objective: Type I sialidosis (ST-1) is a rare autosomal recessive inherited disorder. To date, there has been no study on ST-1 patients in mainland China.

Methods: We reported in detail the cases of five Chinese ST-1 patients from two centers, and summarized all worldwide cases. Then, we compared the differences between Chinese and foreign patients.

Results: A total of 77 genetically confirmed ST-1 patients were identified: 12 from mainland China, 23 from Taiwan, 10 from other Asian regions, and 32 from European and American regions. The mean age of onset was 16.0 ± 6.7 years; the most common symptoms were myoclonus seizures (96.0%), followed by ataxia (94.3%), and blurred vision (67.2%). Compared to other groups, the onset age of patients from mainland China was much younger (10.8 ± 2.7 years). The incidence of visual impairment was lower in patients from other Asian regions than in patients from mainland China and Taiwan (28.6% vs. 81.8%-100%). Cherry-red spots were less frequent in the Taiwanese patients than in patients from other regions (27.3% vs. 55.2%-90.0%). Furthermore, 48 different mutation types were identified. Chinese mainland and Taiwanese patients were more likely to carry the c.544A > G mutation (75% and 100%, respectively) than the patients from other regions (only 0%-10.0%). Approximately 50% of Chinese mainland patients carried the c.239C > T mutation, a much higher proportion than that found in the other populations. In addition, although the brain MRI of most patients was normal, 18 F-FDG-PET analysis could reveal cerebellar and occipital lobe hypometabolism.

Interpretation: ST-1 patients in different regions are likely to have different mutation types; environmental factors may influence clinical manifestations. Larger studies enrolling more patients are required.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Cerebellum / diagnostic imaging
  • Cerebellum / metabolism
  • China
  • Female
  • Humans
  • Incidence
  • Male
  • Mucolipidoses / complications
  • Mucolipidoses / diagnostic imaging
  • Mucolipidoses / genetics*
  • Mucolipidoses / physiopathology*
  • Occipital Lobe / diagnostic imaging
  • Occipital Lobe / metabolism
  • Positron-Emission Tomography
  • Vision Disorders / epidemiology
  • Vision Disorders / etiology
  • Young Adult

Supplementary concepts

  • Neuraminidase 1 deficiency

Grants and funding

This work was funded by the Application Research of Capital Clinical Characteristics grant Z181100001718082; the Beijing Dongcheng District Outstanding Talent Funding Project grant 2019DCT‐M‐18; the National Key R&D Program of China grant 2017YFC1307500.